{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:49:32Z","timestamp":1790873372071,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,5,23]],"date-time":"2006-05-23T00:00:00Z","timestamp":1148342400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Peptidase inhibitor 3 (PI3) inhibits neutrophil elastase and proteinase-3, and has a potential role in skin and lung diseases as well as in cancer. Genome-wide expression profiling of chorioamniotic membranes revealed decreased expression of PI3 in women with preterm premature rupture of membranes. To elucidate the molecular mechanisms contributing to the decreased expression in amniotic membranes, the PI3 gene was searched for sequence variations and the functional significance of the identified promoter variants was studied.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Single nucleotide polymorphisms (SNPs) were identified by direct sequencing of PCR products spanning a region from 1,173 bp upstream to 1,266 bp downstream of the translation start site. Fourteen SNPs were genotyped from 112 and nine SNPs from 24 unrelated individuals. Putative transcription factor binding sites as detected by <jats:italic>in silico<\/jats:italic> search were verified by electrophoretic mobility shift assay (EMSA) using nuclear extract from Hela and amnion cell nuclear extract. Deviation from Hardy-Weinberg equilibrium (HWE) was tested by \u03c7<jats:sup>2<\/jats:sup> goodness-of-fit test. Haplotypes were estimated using expectation maximization (EM) algorithm.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Twenty-three sequence variations were identified by direct sequencing of polymerase chain reaction (PCR) products covering 2,439 nt of the PI3 gene (-1,173 nt of promoter sequences and all three exons). Analysis of 112 unrelated individuals showed that 20 variants had minor allele frequencies (MAF) ranging from 0.02 to 0.46 representing \"true polymorphisms\", while three had MAF \u2264 0.01. Eleven variants were in the promoter region; several putative transcription factor binding sites were found at these sites by database searches. Differential binding of transcription factors was demonstrated at two polymorphic sites by electrophoretic mobility shift assays, both in amniotic and HeLa cell nuclear extracts. Differential binding of the transcription factor GATA1 at -689C&gt;G site was confirmed by a supershift.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The promoter sequences of PI3 have a high degree of variability. Functional promoter variants provide a possible mechanism for explaining the differences in PI3 mRNA expression levels in the chorioamniotic membranes, and are also likely to be useful in elucidating the role of PI3 in other diseases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2350-7-49","type":"journal-article","created":{"date-parts":[[2006,5,23]],"date-time":"2006-05-23T18:27:00Z","timestamp":1148408820000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Identification of novel functional sequence variants in the gene for peptidase inhibitor 3"],"prefix":"10.1186","volume":"7","author":[{"given":"Mahboob A","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Kuivaniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Edwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinnakorn","family":"Chaiworapongsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Tromp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,5,23]]},"reference":[{"key":"157_CR1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1042\/bj3400569","volume":"340","author":"J Schalkwijk","year":"1999","unstructured":"Schalkwijk J, Wiedow O, Hirose S: The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core. Biochem J. 1999, 340: 569-577. 10.1042\/0264-6021:3400569.","journal-title":"Biochem J"},{"issue":"4","key":"157_CR2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1165\/ajrcmb\/8.4.439","volume":"8","author":"JM Sallenave","year":"1993","unstructured":"Sallenave JM, Silva A: Characterization and gene sequence of the precursor of elafin, an elastase-specific inhibitor in bronchial secretions. Am J Respir Cell Mol Biol. 1993, 8 (4): 439-445.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"Pt 1","key":"157_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1042\/bj20020869","volume":"368","author":"A Clauss","year":"2002","unstructured":"Clauss A, Lilja H, Lundwall A: A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein. Biochem J. 2002, 368 (Pt 1): 233-242. 10.1042\/BJ20020869.","journal-title":"Biochem J"},{"issue":"1","key":"157_CR4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0006-291X(05)80981-7","volume":"185","author":"T Saheki","year":"1992","unstructured":"Saheki T, Ito F, Hagiwara H, Saito Y, Kuroki J, Tachibana S, Hirose S: Primary structure of the human elafin precursor preproelafin deduced from the nucleotide sequence of its gene and the presence of unique repetitive sequences in the prosegment. Biochem Biophys Res Commun. 1992, 185 (1): 240-245. 10.1016\/S0006-291X(05)80981-7.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"157_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1046\/j.1523-1747.2003.12043.x","volume":"120","author":"A Pol","year":"2003","unstructured":"Pol A, Pfundt R, Zeeuwen P, Molhuizen H, Schalkwijk J: Transcriptional regulation of the elafin gene in human keratinocytes. J Invest Dermatol. 2003, 120 (2): 301-307. 10.1046\/j.1523-1747.2003.12043.x.","journal-title":"J Invest Dermatol"},{"issue":"25","key":"157_CR6","doi-asserted-by":"crossref","first-page":"14791","DOI":"10.1016\/S0021-9258(18)77182-2","volume":"265","author":"O Wiedow","year":"1990","unstructured":"Wiedow O, Schroder JM, Gregory H, Young JA, Christophers E: Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. J Biol Chem. 1990, 265 (25): 14791-14795.","journal-title":"J Biol Chem"},{"issue":"1","key":"157_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1515\/bchm3.1992.373.1.27","volume":"373","author":"JM Sallenave","year":"1992","unstructured":"Sallenave JM, Marsden MD, Ryle AP: Isolation of elafin and elastase-specific inhibitor (ESI) from bronchial secretions. Evidence of sequence homology and immunological cross-reactivity. Biol Chem Hoppe Seyler. 1992, 373 (1): 27-33.","journal-title":"Biol Chem Hoppe Seyler"},{"issue":"6","key":"157_CR8","first-page":"1679","volume":"143","author":"HA Alkemade","year":"1993","unstructured":"Alkemade HA, Molhuizen HO, van Vlijmen-Willems IM, van Haelst UJ, Schalkwijk J: Differential expression of SKALP\/Elafin in human epidermal tumors. Am J Pathol. 1993, 143 (6): 1679-1687.","journal-title":"Am J Pathol"},{"issue":"12","key":"157_CR9","first-page":"2537","volume":"55","author":"M Zhang","year":"1995","unstructured":"Zhang M, Zou Z, Maass N, Sager R: Differential expression of elafin in human normal mammary epithelial cells and carcinomas is regulated at the transcriptional level. Cancer Res. 1995, 55 (12): 2537-2541.","journal-title":"Cancer Res"},{"issue":"11","key":"157_CR10","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1128\/iai.64.11.4520-4524.1996","volume":"64","author":"PS Hiemstra","year":"1996","unstructured":"Hiemstra PS, Maassen RJ, Stolk J, Heinzel-Wieland R, Steffens GJ, Dijkman JH: Antibacterial activity of antileukoprotease. Infect Immun. 1996, 64 (11): 4520-4524.","journal-title":"Infect Immun"},{"issue":"2","key":"157_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1042\/bst0300111","volume":"30","author":"JM Sallenave","year":"2002","unstructured":"Sallenave JM: Antimicrobial activity of antiproteinases. Biochem Soc Trans. 2002, 30 (2): 111-115. 10.1042\/BST0300111.","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"157_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0014-5793(99)00670-5","volume":"452","author":"AJ Simpson","year":"1999","unstructured":"Simpson AJ, Maxwell AI, Govan JR, Haslett C, Sallenave JM: Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens. FEBS Lett. 1999, 452 (3): 309-313. 10.1016\/S0014-5793(99)00670-5.","journal-title":"FEBS Lett"},{"issue":"3","key":"157_CR13","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1006\/bbrc.1998.9069","volume":"248","author":"O Wiedow","year":"1998","unstructured":"Wiedow O, Harder J, Bartels J, Streit V, Christophers E: Antileukoprotease in human skin: an antibiotic peptide constitutively produced by keratinocytes. Biochem Biophys Res Commun. 1998, 248 (3): 904-909. 10.1006\/bbrc.1998.9069.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"157_CR14","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1165\/ajrcmb.11.6.7946401","volume":"11","author":"JM Sallenave","year":"1994","unstructured":"Sallenave JM, Shulmann J, Crossley J, Jordana M, Gauldie J: Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI\/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am J Respir Cell Mol Biol. 1994, 11 (6): 733-741.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"157_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1165\/ajrcmb.25.1.4341","volume":"25","author":"L Bingle","year":"2001","unstructured":"Bingle L, Tetley TD, Bingle CD: Cytokine-mediated induction of the human elafin gene in pulmonary epithelial cells is regulated by nuclear factor-kappaB. Am J Respir Cell Mol Biol. 2001, 25 (1): 84-91.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"157_CR16","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.ajog.2004.07.010","volume":"191","author":"G Tromp","year":"2004","unstructured":"Tromp G, Kuivaniemi H, Romero R, Chaiworapongsa T, Kim YM, Kim MR, Maymon E, Edwin S: Genome-wide expression profiling of fetal membranes reveals a deficient expression of protease inhibitor 3 in premature rupture of membranes. American Journal of Obstetrics and Gynecology. 2004, 191: 1331-1338. 10.1016\/j.ajog.2004.07.010.","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"157_CR17","unstructured":"Hall T: BioEdit Sequence Alignment Editor for Windows 95\/98\/NT\/XP. [http:\/\/www.mbio.ncsu.edu\/BioEdit\/bioedit.html]"},{"key":"157_CR18","unstructured":"Schug J, Overton GC: TESS : Transcription Element Search System. [http:\/\/www.cbil.upenn.edu\/cgi-bin\/tess\/tess]"},{"key":"157_CR19","first-page":"268","volume":"5","author":"J Schug","year":"1997","unstructured":"Schug J, Overton GC: Modeling transcription factor binding sites with Gibbs Sampling and Minimum Description Length encoding. Proc Int Conf Intell Syst Mol Biol. 1997, 5: 268-271.","journal-title":"Proc Int Conf Intell Syst Mol Biol"},{"key":"157_CR20","unstructured":"Grabe N: AliBaba 2.1. [http:\/\/darwin.nmsu.edu\/~molb470\/fall2003\/Projects\/solorz\/aliBaba_2_1.htm]"},{"issue":"1","key":"157_CR21","first-page":"S1","volume":"2","author":"N Grabe","year":"2002","unstructured":"Grabe N: AliBaba2: context specific identification of transcription factor binding sites. In Silico Biol. 2002, 2 (1): S1-1.","journal-title":"In Silico Biol"},{"key":"157_CR22","unstructured":"Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T: Genomatix Software GmbH - GEMS Launcher. [http:\/\/www.genomatix.de\/products\/MatInspector\/index.html]"},{"key":"157_CR23","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1093\/nar\/23.23.4878","volume":"23","author":"K Quandt","year":"1995","unstructured":"Quandt K, Frech K, Karas H, Wingender E, Werner T: MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 1995, 23: 4878-4884.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"157_CR24","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/nar\/11.5.1475","volume":"11","author":"JD Dignam","year":"1983","unstructured":"Dignam JD, Lebovitz RM, Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983, 11 (5): 1475-1489.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"157_CR25","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1182\/blood.V89.4.1182","volume":"89","author":"BN Komatsu","year":"1997","unstructured":"Komatsu BN, Kirito K, Kashii Y, Furukawa Y, Kikuchi J, Suwabe N, Yamamoto M, Miura Y: Cell-cycle-dependent regulation of erythropoietin receptor gene. Blood. 1997, 89 (4): 1182-1188.","journal-title":"Blood"},{"key":"157_CR26","unstructured":"Mutation Nomenclature. [http:\/\/www.hgvs.org\/mutnomen\/]"},{"key":"157_CR27","unstructured":"Povey S: HGNC Home Page. [http:\/\/www.gene.ucl.ac.uk\/nomenclature]"},{"key":"157_CR28","unstructured":"Excoffier L: Arlequin's Home on the Web. [http:\/\/anthro.unige.ch\/arlequin\/]"},{"key":"157_CR29","unstructured":"dbSNP Home Page. [http:\/\/www.ncbi.nlm.nih.gov\/SNP\/]"},{"issue":"19","key":"157_CR30","doi-asserted-by":"publisher","first-page":"6712","DOI":"10.1073\/pnas.84.19.6712","volume":"84","author":"JT Moore","year":"1987","unstructured":"Moore JT, Hagstrom J, McCormick DJ, Harvey S, Madden B, Holicky E, Stanford DR, Wieben ED: The major clotting protein from guinea pig seminal vesicle contains eight repeats of a 24-amino acid domain. Proc Natl Acad Sci U S A. 1987, 84 (19): 6712-6714. 10.1073\/pnas.84.19.6712.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"157_CR31","first-page":"4631","volume":"57","author":"M Zhang","year":"1997","unstructured":"Zhang M, Magit D, Pardee AB, Sager R: Re-expression of elafin in 21MT2 breast carcinomas by phorbol 12-myristate 13-acetate is mediated by the Ap1 site in the elafin promoter. Cancer Res. 1997, 57 (20): 4631-4636.","journal-title":"Cancer Res"},{"issue":"4","key":"157_CR32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/jmf.12.4.237.246","volume":"12","author":"BR Helmig","year":"2002","unstructured":"Helmig BR, Romero R, Espinoza J, Chaiworapongsa T, Bujold E, Gomez R, Ohlsson K, Uldbjerg N: Neutrophil elastase and secretory leukocyte protease inhibitor in prelabor rupture of membranes, parturition and intra-amniotic infection. J Matern Fetal Neonatal Med. 2002, 12 (4): 237-246.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"157_CR33","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1365-2133.1990.tb07285.x","volume":"122","author":"J Schalkwijk","year":"1990","unstructured":"Schalkwijk J, Chang A, Janssen P, de Jongh GJ, Mier PD: Skin-derived antileucoproteinase (SKALP): characterization of two new elastase inhibitors from psoriatic epidermis. Br J Dermatol. 1990, 122: 631-641.","journal-title":"Br J Dermatol"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-7-49.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2350-7-49\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-7-49","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-7-49.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:42:13Z","timestamp":1630456933000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/1471-2350-7-49"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,23]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["157"],"URL":"https:\/\/doi.org\/10.1186\/1471-2350-7-49","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,23]]},"assertion":[{"value":"8 March 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"49"}}